Skip to main content
Erschienen in: Journal of Assisted Reproduction and Genetics 9/2018

04.06.2018 | Assisted Reproduction Technologies

Decreased pregnancy and live birth rates after vitrification of in vitro matured oocytes

verfasst von: Yoni Cohen, Alexandra St-Onge-St-Hilaire, Samer Tannus, Grace Younes, Michael H. Dahan, William Buckett, Weon-Young Son

Erschienen in: Journal of Assisted Reproduction and Genetics | Ausgabe 9/2018

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To assess effects on fertilization rate, embryo quality, pregnancy, and live birth rates of vitrification and warming of oocytes that matured in vitro (vIVM) compared to fresh in vitro maturation (fIVM) cycles.

Methods

A retrospective cohort study conducted at a university hospital-affiliated IVF unit. Fifty-six cycles of vIVM cycles and 263 fIVM in women diagnosed with polycystic ovarian syndrome (PCOS) ovaries were included in the analysis. The study group included PCOS patients who failed ovulation induction with intrauterine insemination and were offered IVM cycle followed by oocyte vitrification and warming. The embryological aspects and clinical outcomes were compared to those of controls undergoing fresh IVM cycles during the same period. The main outcome measure was live birth rate.

Results

One thousand seventy oocytes were collected from 56 patients and underwent vitrification and warming. In the control group, 4781 oocytes were collected from 219 patients who had undergone a fresh IVM cycle. Oocyte maturation rates were similar between the groups (mean ± SD: 0.7 ± 0.2 vs. 0.6 ± 0.2, for vIVM and fIVM, respectively). Survival rate after warming was 59.8%. Fertilization and embryo cleavage rates per oocyte were significantly lower in the vIVM group. Clinical pregnancy (10.7 vs. 36.1%) and live birth rates (8.9 vs. 25.9%) per cycle were significantly lower in the vIVM group than those in the fIVM group (P = 0.005 and P < 0.001, respectively). Five healthy babies were born in the vIVM group.

Conclusions

The reproductive potential of vitrified IVM oocytes is impaired. This injury likely occurs through vitrification and warming.
Literatur
1.
Zurück zum Zitat Liu J, Lu G, Qian Y, Mao Y, Ding W. Pregnancies and births achieved from in vitro matured oocytes retrieved from poor responders undergoing stimulation in in vitro fertilization cycles. Fertil Steril. 2003;80:447–9.CrossRefPubMed Liu J, Lu G, Qian Y, Mao Y, Ding W. Pregnancies and births achieved from in vitro matured oocytes retrieved from poor responders undergoing stimulation in in vitro fertilization cycles. Fertil Steril. 2003;80:447–9.CrossRefPubMed
3.
Zurück zum Zitat Creux H, Monnier P, Son WY, Tulandi T, Buckett W. Immature oocyte retrieval and in vitro oocyte maturation at different phases of the menstrual cycle in women with cancer who require urgent gonadotoxic treatment. Fertil Steril. 2017;107:198–204.CrossRefPubMed Creux H, Monnier P, Son WY, Tulandi T, Buckett W. Immature oocyte retrieval and in vitro oocyte maturation at different phases of the menstrual cycle in women with cancer who require urgent gonadotoxic treatment. Fertil Steril. 2017;107:198–204.CrossRefPubMed
4.
Zurück zum Zitat Abir R, Ben-Aharon I, Garor R, Yaniv I, Ash S, Stemmer SM, et al. Cryopreservation of in vitro matured oocytes in addition to ovarian tissue freezing for fertility preservation in paediatric female cancer patients before and after cancer therapy. Hum Reprod. 2016;31:750–62.CrossRefPubMed Abir R, Ben-Aharon I, Garor R, Yaniv I, Ash S, Stemmer SM, et al. Cryopreservation of in vitro matured oocytes in addition to ovarian tissue freezing for fertility preservation in paediatric female cancer patients before and after cancer therapy. Hum Reprod. 2016;31:750–62.CrossRefPubMed
5.
Zurück zum Zitat Cobo A, García-Velasco JA, Coello A, Domingo J, Pellicer A, Remohí J. Oocyte vitrification as an efficient option for elective fertility preservation. Fertil Steril. 2016;105:755–764e8.CrossRefPubMed Cobo A, García-Velasco JA, Coello A, Domingo J, Pellicer A, Remohí J. Oocyte vitrification as an efficient option for elective fertility preservation. Fertil Steril. 2016;105:755–764e8.CrossRefPubMed
6.
Zurück zum Zitat Kuwayama M, Vajta G, Kato O, Leibo SP. Highly efficient vitrification method for cryopreservation of human oocytes. Reprod BioMed Online. 2005;11:300–8.CrossRefPubMed Kuwayama M, Vajta G, Kato O, Leibo SP. Highly efficient vitrification method for cryopreservation of human oocytes. Reprod BioMed Online. 2005;11:300–8.CrossRefPubMed
7.
Zurück zum Zitat Shalom-Paz E, Almog B, Shehata F, Huang J, Holzer H, Chian RC, et al. Fertility preservation for breast-cancer patients using IVM followed by oocyte or embryo vitrification. Reprod BioMed Online. 2010;21:566–71.CrossRefPubMed Shalom-Paz E, Almog B, Shehata F, Huang J, Holzer H, Chian RC, et al. Fertility preservation for breast-cancer patients using IVM followed by oocyte or embryo vitrification. Reprod BioMed Online. 2010;21:566–71.CrossRefPubMed
8.
Zurück zum Zitat Ali A, Benkhalifa M, Miron P. In-vitro maturation of oocytes: biological aspects. Reprod BioMed Online. 2006;13:437–46.CrossRefPubMed Ali A, Benkhalifa M, Miron P. In-vitro maturation of oocytes: biological aspects. Reprod BioMed Online. 2006;13:437–46.CrossRefPubMed
9.
Zurück zum Zitat Sanfins A, Plancha CE, Overstrom EW, Albertini DF. Meiotic spindle morphogenesis in in vivo and in vitro matured mouse oocytes: insights into the relationship between nuclear and cytoplasmic quality. Hum Reprod. 2004;19:2889–99.CrossRefPubMed Sanfins A, Plancha CE, Overstrom EW, Albertini DF. Meiotic spindle morphogenesis in in vivo and in vitro matured mouse oocytes: insights into the relationship between nuclear and cytoplasmic quality. Hum Reprod. 2004;19:2889–99.CrossRefPubMed
10.
Zurück zum Zitat Walls ML, Ryan JP, Keelan JA, Hart R. In vitro maturation is associated with increased early embryo arrest without impairing morphokinetic development of useable embryos progressing to blastocysts. Hum Reprod. 2015;30:1842–9.CrossRefPubMed Walls ML, Ryan JP, Keelan JA, Hart R. In vitro maturation is associated with increased early embryo arrest without impairing morphokinetic development of useable embryos progressing to blastocysts. Hum Reprod. 2015;30:1842–9.CrossRefPubMed
11.
Zurück zum Zitat Walls ML, Hart R, Keelan JA, Ryan JP. Structural and morphologic differences in human oocytes after in vitro maturation compared with standard in vitro fertilization. Fertil. Steril. 2016;106:1392–1398.e5.CrossRefPubMed Walls ML, Hart R, Keelan JA, Ryan JP. Structural and morphologic differences in human oocytes after in vitro maturation compared with standard in vitro fertilization. Fertil. Steril. 2016;106:1392–1398.e5.CrossRefPubMed
12.
Zurück zum Zitat Brambillasca F, Guglielmo MC, Coticchio G, Mignini Renzini M, Dal Canto M, Fadini R. The current challenges to efficient immature oocyte cryopreservation. J Assist Reprod Genet. 2013;30:1531–9.CrossRefPubMedPubMedCentral Brambillasca F, Guglielmo MC, Coticchio G, Mignini Renzini M, Dal Canto M, Fadini R. The current challenges to efficient immature oocyte cryopreservation. J Assist Reprod Genet. 2013;30:1531–9.CrossRefPubMedPubMedCentral
13.
Zurück zum Zitat Lei T, Guo N, Liu J-Q, Tan M-H, Li Y-F. Vitrification of in vitro matured oocytes: effects on meiotic spindle configuration and mitochondrial function. Int J Clin Exp Pathol. 2014;7:1159–65.PubMedPubMedCentral Lei T, Guo N, Liu J-Q, Tan M-H, Li Y-F. Vitrification of in vitro matured oocytes: effects on meiotic spindle configuration and mitochondrial function. Int J Clin Exp Pathol. 2014;7:1159–65.PubMedPubMedCentral
14.
Zurück zum Zitat Chian RC, Huang JYJ, Gilbert L, Son WY, Holzer H, Cui SJ, et al. Obstetric outcomes following vitrification of in vitro and in vivo matured oocytes. Fertil Steril. 2009;91:2391–8.CrossRefPubMed Chian RC, Huang JYJ, Gilbert L, Son WY, Holzer H, Cui SJ, et al. Obstetric outcomes following vitrification of in vitro and in vivo matured oocytes. Fertil Steril. 2009;91:2391–8.CrossRefPubMed
15.
Zurück zum Zitat Rotterdam ESHRE/ASRM-Sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod. 2004;19:41–7.CrossRef Rotterdam ESHRE/ASRM-Sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod. 2004;19:41–7.CrossRef
16.
Zurück zum Zitat Son WY, Chung JT, Demirtas E, Holzer H, Sylvestre C, Buckett W, et al. Comparison of in-vitro maturation cycles with and without in-vivo matured oocytes retrieved. Reprod BioMed Online. 2008;17:59–67.CrossRefPubMed Son WY, Chung JT, Demirtas E, Holzer H, Sylvestre C, Buckett W, et al. Comparison of in-vitro maturation cycles with and without in-vivo matured oocytes retrieved. Reprod BioMed Online. 2008;17:59–67.CrossRefPubMed
17.
Zurück zum Zitat Son WY, Tan SL. Laboratory and embryological aspects of hCG-primed in vitro maturation cycles for patients with polycystic ovaries. Hum Reprod Update. 2010;16:675–89.CrossRefPubMed Son WY, Tan SL. Laboratory and embryological aspects of hCG-primed in vitro maturation cycles for patients with polycystic ovaries. Hum Reprod Update. 2010;16:675–89.CrossRefPubMed
18.
Zurück zum Zitat Shalom-Paz E, Holzer H, Young Son W, Levin I, Tan SL, Almog B. PCOS patients can benefit from in vitro maturation (IVM) of oocytes. Eur J Obstet Gynecol Reprod Biol. 2012;165:53–6.CrossRefPubMed Shalom-Paz E, Holzer H, Young Son W, Levin I, Tan SL, Almog B. PCOS patients can benefit from in vitro maturation (IVM) of oocytes. Eur J Obstet Gynecol Reprod Biol. 2012;165:53–6.CrossRefPubMed
19.
Zurück zum Zitat Cao Y, Xing Q, Zhang Z-G, Wei Z-L, Zhou P, Cong L. Cryopreservation of immature and in-vitro matured human oocytes by vitrification. Reprod BioMed Online. 2009;19:369–73.CrossRefPubMed Cao Y, Xing Q, Zhang Z-G, Wei Z-L, Zhou P, Cong L. Cryopreservation of immature and in-vitro matured human oocytes by vitrification. Reprod BioMed Online. 2009;19:369–73.CrossRefPubMed
20.
21.
Zurück zum Zitat Wang H, Racowsky C, Combelles CMH. Is it best to cryopreserve human cumulus-free immature oocytes before or after in vitro maturation? Cryobiology. 2012;65:79–87.CrossRefPubMed Wang H, Racowsky C, Combelles CMH. Is it best to cryopreserve human cumulus-free immature oocytes before or after in vitro maturation? Cryobiology. 2012;65:79–87.CrossRefPubMed
22.
Zurück zum Zitat Benkhalifa M, Demirol A, Menezo Y, Balashova E, Abduljalil AK, Abbas S, et al. Natural cycle IVF and oocyte in-vitro maturation in polycystic ovary syndrome: a collaborative prospective study. ReprodBiomedOnline. 2009;18:29–36. Benkhalifa M, Demirol A, Menezo Y, Balashova E, Abduljalil AK, Abbas S, et al. Natural cycle IVF and oocyte in-vitro maturation in polycystic ovary syndrome: a collaborative prospective study. ReprodBiomedOnline. 2009;18:29–36.
23.
Zurück zum Zitat Druckenmiller S, Goldman KN, Labella PA, Fino ME, Bazzocchi A, Noyes N. Successful oocyte cryopreservation in reproductive-aged cancer survivors. Obstet Gynecol. 2016;127:474–80.CrossRefPubMed Druckenmiller S, Goldman KN, Labella PA, Fino ME, Bazzocchi A, Noyes N. Successful oocyte cryopreservation in reproductive-aged cancer survivors. Obstet Gynecol. 2016;127:474–80.CrossRefPubMed
24.
Zurück zum Zitat Cooper A, Paynter SJ, Fuller BJ, Shaw RW. Differential effects of cryopreservation on nuclear or cytoplasmic maturation in vitro in immature mouse oocytes from stimulated ovaries. Hum Reprod. 1998;13:971–8.CrossRefPubMed Cooper A, Paynter SJ, Fuller BJ, Shaw RW. Differential effects of cryopreservation on nuclear or cytoplasmic maturation in vitro in immature mouse oocytes from stimulated ovaries. Hum Reprod. 1998;13:971–8.CrossRefPubMed
25.
Zurück zum Zitat Hu W, Marchesi D, Qiao J, Feng HL. Effect of slow freeze versus vitrification on the oocyte: an animal model. Fertil Steril. 2012;98:752–760.e3.CrossRefPubMed Hu W, Marchesi D, Qiao J, Feng HL. Effect of slow freeze versus vitrification on the oocyte: an animal model. Fertil Steril. 2012;98:752–760.e3.CrossRefPubMed
26.
Zurück zum Zitat Matson PL, Graefling J, Junk SM, Yovich JL, Edirisinghe WR. Cryopreservation of oocytes and embryos: use of a mouse model to investigate effects upon zona hardness and formulate treatment strategies in an in-vitro fertilization programme. Hum Reprod. 1997;12:1550–3.CrossRefPubMed Matson PL, Graefling J, Junk SM, Yovich JL, Edirisinghe WR. Cryopreservation of oocytes and embryos: use of a mouse model to investigate effects upon zona hardness and formulate treatment strategies in an in-vitro fertilization programme. Hum Reprod. 1997;12:1550–3.CrossRefPubMed
27.
Zurück zum Zitat Gook DA, Osborn SM, Johnston WI. Cryopreservation of mouse and human oocytes using 1,2-propanediol and the configuration of the meiotic spindle. Hum Reprod. 1993;8:1101–9.CrossRefPubMed Gook DA, Osborn SM, Johnston WI. Cryopreservation of mouse and human oocytes using 1,2-propanediol and the configuration of the meiotic spindle. Hum Reprod. 1993;8:1101–9.CrossRefPubMed
28.
Zurück zum Zitat Huang JYJ, Chen HY, Park JYS, Tan SL, Chian RC. Comparison of spindle and chromosome configuration in in vitro- and in vivo-matured mouse oocytes after vitrification. Fertil Steril. 2008;90:1424–32.CrossRefPubMed Huang JYJ, Chen HY, Park JYS, Tan SL, Chian RC. Comparison of spindle and chromosome configuration in in vitro- and in vivo-matured mouse oocytes after vitrification. Fertil Steril. 2008;90:1424–32.CrossRefPubMed
29.
Zurück zum Zitat Prasath EB, Chan MLH, Wong WHW, Lim CJW, Tharmalingam MD, Hendricks M, et al. First pregnancy and live birth resulting from cryopreserved embryos obtained from in vitro matured oocytes after oophorectomy in an ovarian cancer patient. Hum Reprod. 2014;29:276–8.CrossRefPubMed Prasath EB, Chan MLH, Wong WHW, Lim CJW, Tharmalingam MD, Hendricks M, et al. First pregnancy and live birth resulting from cryopreserved embryos obtained from in vitro matured oocytes after oophorectomy in an ovarian cancer patient. Hum Reprod. 2014;29:276–8.CrossRefPubMed
30.
Zurück zum Zitat Uzelac PS, Delaney AA, Christensen GL, Bohler HCL, Nakajima ST. Live birth following in vitro maturation of oocytes retrieved from extracorporeal ovarian tissue aspiration and embryo cryopreservation for 5 years. Fertil Steril. 2015;104:1258–60.CrossRefPubMed Uzelac PS, Delaney AA, Christensen GL, Bohler HCL, Nakajima ST. Live birth following in vitro maturation of oocytes retrieved from extracorporeal ovarian tissue aspiration and embryo cryopreservation for 5 years. Fertil Steril. 2015;104:1258–60.CrossRefPubMed
31.
Zurück zum Zitat Dahan MH, Tan SL, Chung J, Son WY. Clinical definition paper on in vitro maturation of human oocytes. Hum Reprod. 2016;31:1383–6.CrossRefPubMed Dahan MH, Tan SL, Chung J, Son WY. Clinical definition paper on in vitro maturation of human oocytes. Hum Reprod. 2016;31:1383–6.CrossRefPubMed
Metadaten
Titel
Decreased pregnancy and live birth rates after vitrification of in vitro matured oocytes
verfasst von
Yoni Cohen
Alexandra St-Onge-St-Hilaire
Samer Tannus
Grace Younes
Michael H. Dahan
William Buckett
Weon-Young Son
Publikationsdatum
04.06.2018
Verlag
Springer US
Erschienen in
Journal of Assisted Reproduction and Genetics / Ausgabe 9/2018
Print ISSN: 1058-0468
Elektronische ISSN: 1573-7330
DOI
https://doi.org/10.1007/s10815-018-1216-3

Weitere Artikel der Ausgabe 9/2018

Journal of Assisted Reproduction and Genetics 9/2018 Zur Ausgabe

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.